AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OptimizeRx Corp Director's Dealing 2021

Feb 12, 2021

33090_dirs_2021-02-12_29a7b820-6bf4-4d60-ae97-e2d644b8479e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2021-02-11

Reporting Person: Odence-Ford Marion (General Counsel and CCO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-11	Unvested Restricted Stock Award	$	A	20000	Acquired	2026-02-11	Common (20000)	Direct

Footnotes

F1: The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 1/5 at the end of each anniversary from issuance.